Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An online fundraising appeal for coronavirus (COVID-19) research at Oxford has raised more than £50,000 from over 200 individuals after launching just two weeks ago. The donations will be deployed immediately, boosting projects ranging from vaccine development to the delivery of new drugs to treat the virus.

This transmission electron microscope image shows SARS-CoV-2, isolated from a patient in the U.S., emerging from the surface of cells cultured in the lab © NIAID-RML
This transmission electron microscope image shows SARS-CoV-2, isolated from a patient in the U.S., emerging from the surface of cells cultured in the lab

The University is at the forefront of global efforts to understand and control the coronavirus pandemic, with around 90 principal investigators and 1,300 researchers, post-docs and students working around the clock to develop effective vaccines, drugs and public health measures.

Oxford is in a unique position to tackle the pandemic, but access to flexible funding is essential. Donations of all sizes will have an immediate impact on the University’s response to the crisis, filling gaps in funding to ensure that clinical trials can continue, that supply lines keep moving, and that researchers are able to work at both speed and scale.

Read the full story on the University of Oxford Development Office website

Update (16.04.20): The fundraising appeal has now raised a fanastic £85,000 - and counting!

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.